Clinical Cancer Research Meeting Calendar Advances in Breast Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Cancer Research 13, 2614, May 1, 2007. doi: 10.1158/1078-0432.CCR-06-1187
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kader, A. K.
Right arrow Articles by Wu, X.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kader, A. K.
Right arrow Articles by Wu, X.

Imaging, Diagnosis, Prognosis

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

A. Karim Kader1,2, Jun Liu1, Lina Shao1, Colin P. Dinney2, Jie Lin1, Yunfei Wang1, Jian Gu1, H. Barton Grossman2 and Xifeng Wu1

Authors' Affiliations: Departments of 1 Epidemiology and 2 Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Xifeng Wu, Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Unit 1340, 1155 Pressler Boulevard, Houston, TX 77030. E-mail: xwu{at}mdanderson.org.

Purpose: Matrix metalloproteinases (MMP) promote tumor invasion and alter microenvironment. MMP levels are elevated in bladder cancer patients correlating with more advanced stage. We tested whether polymorphisms in MMP genes modify the risk of bladder cancer invasiveness and whether smoke exposure modifies this risk.

Experimental Design: Using a case-only study, we examined the association of 11 single-nucleotide polymorphisms and one microsatellite polymorphism in MMP genes MMP1, MMP2, MMP3, MMP8, MMP9, and MMP12 with the risk of invasive bladder cancer in 243 Caucasian patients with muscle invasive compared with 315 Caucasian patients with superficial disease.

Results: The MMP9 microsatellite ≥24 CA repeat and MMP12 –82 G alleles were associated with a higher risk of bladder cancer invasiveness [odds ratio (OR), 3.10; 95% confidence interval (95% CI) 1.17-8.23 and OR, 1.50; 95% CI, 1.00-2.28, respectively]. Ever smokers with the MMP9 ≥24 CA repeat allele had a 5.16-fold (95% CI, 1.56-17.1) increased risk of invasiveness compared with wild-type never smokers. Ever smokers with the MMP12 G allele also had an increased risk of bladder cancer invasiveness (OR, 2.32; 95% CI, 1.30-4.12).

Conclusions: Our results suggest that genetic changes in MMPs are associated with the development of invasive bladder cancer.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Nan, T. Niu, D. J. Hunter, and J. Han
Missense Polymorphisms in Matrix Metalloproteinase Genes and Skin Cancer Risk
Cancer Epidemiol. Biomarkers Prev., December 1, 2008; 17(12): 3551 - 3557.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.